VaccinexVCNX
13F holders, Q4 2024 (December 31)1holders −11
0new positions
12sold out
$0.98avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Vaccinex Inc. (VCNX) in their 13F filings, down 11 from Q3 2024. 0 opened new positions and 12 sold out. The largest holder was Barclays PLC ($45).
- Company
- Vaccinex Inc.
- CUSIP
- 918640301
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 12 | $1.1M |
All 13F filers, Q3 2024 → Q4 2024: 19 shares bought and 335,475 shares sold, net −335,456 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Barclays PLC | 0.00% | Add +70.4% | 46 | $45 |
"% of holder's portfolio" is VCNX's weight in each manager's 13F, not the share of Vaccinex Inc. the manager owns.